CannabisNewsBreaks

ThursdayApr 21, 2022 2:07 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Secures First-Ever Patent for DehydraTECH to Deliver Antiviral Drugs

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced its receipt of its first-ever patent for the use of DehydraTECH technology in the enhanced delivery of antiviral drugs. According to the update, Lexaria has received notification from the United States Patent and Trademark Office that patent 11,311,559 for “Compositions and Methods for Enhanced Delivery of Antiviral Agents” will be issued to the company on April 26, 2022. “This will be our 25th patent granted worldwide and another validation of the versatility of our DehydraTECH drug delivery technology,” said Chris Bunka, CEO of Lexaria. “This new…

Continue Reading

ThursdayApr 21, 2022 12:23 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Expansion of Rare Cannabinoid Portfolio

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, is launching business-to-business sales of its rare cannabinoid cannabidivarin (“CBDV”). Through subsidiary BayMedica LLC, InMed will offer its product to wholesalers, suppliers and end-product manufacturers in the health and wellness sector. In addition, the company released a white paper focused on research into the therapeutic potential of CBDV. According to the announcement, CBDV is a nonintoxicating rare cannabinoid that is similar to CBD but offers important differences in activity. One of the most-studied rare cannabinoids, CBDV is currently the focus of several different clinical…

Continue Reading

WednesdayApr 20, 2022 1:59 pm

CannabisNewsBreaks – Hero Technologies Inc. (HENC) Pursuing Diversification, Increased Share in Booming Colorado Market

Hero Technologies (OTC: HENC) anticipates expanding into the booming Colorado cannabis market via cultivation and dispensary operations through its wholly owned subsidiary, Mile High Green LLC. “Cannabis sales in the state broke another record last year, topping $2.22 billion in products sold, according to the Colorado Department of Revenue (https://cnw.fm/SFXzA). This figure ‘eclipses’ 2020 sales reaching upwards of $2.1 billion, which set a previous record,” a recent article reads. “Hero Technologies announced the formation of Mile High Green in March of last year, stating that the purpose of the subsidiary was to seek cannabis, land purchase and strategic acquisition opportunities in…

Continue Reading

WednesdayApr 20, 2022 1:22 pm

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Provides Update Regarding Restructuring, Strengthening of Balance Sheet

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, has completed a companywide restricting, which resulted in the elimination of $115 million in liabilities and more than $22 million in annual expenses. Highlights of the strategic moves include the completion of the sale of its Granville, Illinois, facility; the repayment of $51.7 million secured debt and the elimination of $6.3 million of annualized debt servicing; and transitioning to an asset-light, brand-rich model that eliminated more than $13 million in associated annual operating expenses, inclusive of $8 million in cash operating costs. In…

Continue Reading

TuesdayApr 19, 2022 4:37 pm

CannabisNewsBreaks – O’Cannabiz International Conference and Expo Slated for June Return to Toronto

The O’Cannabiz International Conference and Expo is heading back to Toronto this year; the three-day event is scheduled for June 1–3, 2022. The event is designed for cannabis industry entrepreneurs, growers, researchers, suppliers and retailers, as well as cannabis product consumers. Participants will learn about an array of diverse topics covered in more than 70 breakout sessions and workshops and discussed by more than 180 presenters. In addition, the event features a 50,000,000-square-foot expo hall that spotlights hundreds of exhibitors coming from all corners of the cannabis industry. The event networking opportunities are also invaluable. “We’re pleased to announce we’re…

Continue Reading

TuesdayApr 19, 2022 4:22 pm

CannabisNewsBreaks – Organa Kannalytics Releases Dates for 2022 Southeastern Hemp and Medical Cannabis Convention

Organa Kannalytics, an advocacy organization seeking to bring legitimacy to the hemp and medical cannabis industry through science and education, is hosting the upcoming Southeastern Hemp and Medical Cannabis (“SHMC”) Convention. The event is scheduled for May 12–14, 2022, and will be a live event held in Atlanta and streamed online. The event agenda includes inspiring speakers, insightful breakout sessions and invaluable networking opportunities, making this two-day gathering a can’t-miss convention. In-depth discussion will focus on medical use and practices, business opportunities in the hemp and cannabis space, scientific advancements, and local, state and national legislation impacting the growing cannabis…

Continue Reading

TuesdayApr 19, 2022 3:01 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Commences Its Most Comprehensive Study to Date

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that it has begun its multi-week human clinical hypertension study. The randomized, double blinded, placebo-controlled, cross-over study in 60 people, HYPER-H21-4, is the most comprehensive study ever undertaken by Lexaria. HYPER-H21-4 is designed to enhance Lexaria’s probability of success with its expected subsequent Investigational New Drug (“IND”) application filing to seek U.S. Food and Drug Administration (“FDA”) approval to commence registered clinical testing at phase I level or higher, to be determined in consultation with the FDA. The human study is also expected to enhance Lexaria’s…

Continue Reading

TuesdayApr 19, 2022 12:36 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation in Upcoming Conferences

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, will be involved in several conferences in April and May. Company management will be participating at the Benzinga Spring Cannabis Capital Conference, scheduled for April 20–21, 2022, in Miami Beach, Florida. InMed executives will be meeting virtually with institutions and industry representatives. Company executives will also be at Canaccord Genuity’s sixth annual Global Cannabis Conference held on May 11, 2022. A recording of the company’s presentation will be available on InMed’s investor relations website following the event. Company leaders will also be available for…

Continue Reading

MondayApr 18, 2022 2:39 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expanding Rare Cannabinoid Manufacturing Scale

InMed Pharmaceuticals (NASDAQ: INM), a rare cannabinoid drug developer, is expanding its product manufacturing scale, thanks largely to the acquisition of consumer-focused rare cannabinoids manufacturer BayMedica last year. “InMed’s most-recent Q2 financial statement reported revenues of $0.3 million from commercial sales of cannabichromene (‘CBC’) to the health and wellness market following the BayMedica acquisition. Since January, the company has also been selling cannabicitran (‘CBT’) to the health and wellness market on a B2B basis,” a recent article reads. “The company’s forward-looking focus on bringing new cannabinoid products to commercial scale anticipates scales of cannabidivarin (‘CBDV’) and tetrahydrocannabivarin (‘THCV’) in the…

Continue Reading

MondayApr 18, 2022 1:34 pm

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) on ‘Solid Ground in 2022 and Beyond’

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF), a company positioning itself to be one of the top three multistate operators in the United States in cannabis and hemp-derived product lines, has adopted a strategy anchored in operating a house of brands as it anticipates the commoditization of the cannabis market. “This is going to be a commoditized market, and our strategy is such that we are going to stand on our brands going forward. We just need to fortify what we are doing in the markets that we are in right now,” a recent article quotes RWB CEO Brad…

Continue Reading